Infliximab Prior Authorization, Denials and Appeals in New York
Nearly every health plan sold in New York requires prior authorization before it will pay for infliximab, the tumor necrosis factor blocker sold as Remicade…
Read More »Blog Tag
Nearly every health plan sold in New York requires prior authorization before it will pay for infliximab, the tumor necrosis factor blocker sold as Remicade…
Read More »A first infliximab infusion is a longer appointment than most people expect, and the steps that surprise patients happen before the drip starts. Infliximab is…
Read More »Moving your infliximab infusions from one center to another is an administrative transfer, not a change in treatment. Infliximab, sold as Remicade and as the…
Read More »Most patients starting intravenous immunoglobulin (IVIG) want one number first: how long will this take? The Immune Deficiency Foundation states that IVIG…
Read More »Nearly every health plan sold in New York requires prior authorization before it will pay for intravenous immunoglobulin (IVIG). IVIG is a plasma-derived…
Read More »If you or someone you love is living with ulcerative colitis, you already know it’s more than just a “stomach issue.” It’s a chronic condition that can disrupt…
Read More »Living with Crohn’s disease presents numerous challenges. From painful gastrointestinal symptoms to unexpected flare-ups, managing this chronic inflammatory…
Read More »Infusion therapy plays a vital role in modern healthcare, especially for individuals managing chronic illnesses, nutrient deficiencies, autoimmune disorders,…
Read More »Modern medicine has made remarkable advances in how treatments are administered, especially for patients dealing with chronic conditions or complex illnesses.…
Read More »